Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12931-016-0425-5
Published Online: 2016-09-10
Published Print: 2016-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Miravitlles, Marc
D’Urzo, Anthony
Singh, Dave
Koblizek, Vladimir
Funding for this research was provided by:
Novartis Pharma AG